Format

Send to

Choose Destination
PLoS One. 2010 May 12;5(5):e10611. doi: 10.1371/journal.pone.0010611.

Systematic comparison of constitutive promoters and the doxycycline-inducible promoter.

Author information

1
School of Life Sciences, Northeast Normal University, Changchun, China.

Abstract

Constitutive promoters are used routinely to drive ectopic gene expression. Here, we carried out a systematic comparison of eight commonly used constitutive promoters (SV40, CMV, UBC, EF1A, PGK and CAGG for mammalian systems, and COPIA and ACT5C for Drosophila systems). We also included in the comparison the TRE promoter, which can be activated by the rtTA transcriptional activator in a doxycycline-inducible manner. To make our findings representative, we conducted the comparison in a variety of cell types derived from several species. We found that these promoters vary considerably from one another in their strength. Most promoters have fairly consistent strengths across different cell types, but the CMV promoter can vary considerably from cell type to cell type. At maximal induction, the TRE promoter is comparable to a strong constitutive promoter. These results should facilitate more rational choices of promoters in ectopic gene expression studies.

PMID:
20485554
PMCID:
PMC2868906
DOI:
10.1371/journal.pone.0010611
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center